| Product Code: ETC7647659 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cell and Gene Therapy Manufacturing Services Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cell and Gene Therapy Manufacturing Services Market - Industry Life Cycle |
3.4 Israel Cell and Gene Therapy Manufacturing Services Market - Porter's Five Forces |
3.5 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Cell and Gene Therapy Manufacturing Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development in cell and gene therapy |
4.2.2 Growing demand for personalized medicine and advanced therapies |
4.2.3 Favorable government regulations supporting cell and gene therapy manufacturing services |
4.3 Market Restraints |
4.3.1 High cost of cell and gene therapy manufacturing services |
4.3.2 Limited expertise and skilled workforce in the field |
4.3.3 Stringent regulatory requirements and compliance standards |
5 Israel Cell and Gene Therapy Manufacturing Services Market Trends |
6 Israel Cell and Gene Therapy Manufacturing Services Market, By Types |
6.1 Israel Cell and Gene Therapy Manufacturing Services Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.1.4 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.2 Israel Cell and Gene Therapy Manufacturing Services Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Oncology Diseases, 2021- 2031F |
6.2.3 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.4 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Orthopedic Diseases, 2021- 2031F |
6.2.5 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Ophthalmology Diseases, 2021- 2031F |
6.2.6 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Central Nervous System Disorder, 2021- 2031F |
6.2.7 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3 Israel Cell and Gene Therapy Manufacturing Services Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Clinical Manufacturing, 2021- 2031F |
6.3.3 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Commercial Manufacturing, 2021- 2031F |
6.4 Israel Cell and Gene Therapy Manufacturing Services Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.4.4 Israel Cell and Gene Therapy Manufacturing Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cell and Gene Therapy Manufacturing Services Market Import-Export Trade Statistics |
7.1 Israel Cell and Gene Therapy Manufacturing Services Market Export to Major Countries |
7.2 Israel Cell and Gene Therapy Manufacturing Services Market Imports from Major Countries |
8 Israel Cell and Gene Therapy Manufacturing Services Market Key Performance Indicators |
8.1 Average turnaround time for manufacturing cell and gene therapies |
8.2 Rate of successful manufacturing processes |
8.3 Number of collaborations and partnerships with research institutions and biopharmaceutical companies |
8.4 Percentage of manufacturing facilities meeting regulatory compliance standards |
8.5 Customer satisfaction and feedback on service quality |
9 Israel Cell and Gene Therapy Manufacturing Services Market - Opportunity Assessment |
9.1 Israel Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Cell and Gene Therapy Manufacturing Services Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Cell and Gene Therapy Manufacturing Services Market - Competitive Landscape |
10.1 Israel Cell and Gene Therapy Manufacturing Services Market Revenue Share, By Companies, 2024 |
10.2 Israel Cell and Gene Therapy Manufacturing Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here